The company said Nirmatrelvir and Ritonavir tablets will soon be available in a combi-pack, sold under the brand name Paxzen, as a treatment option for patients with mild to moderate symptoms of Covid-19. While the price of medicine is yet to be decided, it will be manufactured at Zenara's USFDA-approved state-of-the-art facility in Hyderabad.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cFuRG8t
via IFTTT
0 comments:
Post a Comment